Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Schoppmeyer, Konrad ^a   Wagner, A D ^b   Mossner J ^b   Fleig, W ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALCOHOL;

CLINICAL STUDY; DRUG ADMINISTRATION ROUTE; EARLY CANCER; LIVER CELL CARCINOMA; METHODOLOGY; OUTCOME ASSESSMENT; REVIEW; TREATMENT OUTCOME;

EID: 44949131794     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006745     Document Type: Review

References (40)

1. Altman 2001 Altman DG. Systematic reviews of evaluations of prognostic variables. In: EggerM editor(s). Systematic Reviews in Health Care. London: BMJ, 2001:228-47.
2. Altman 2003 Altman DG, Bland JM. Interaction revisited: the difference between two estimates. British Medical Journal 2003;326:219.
3. Arii 2000 Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, et al.Results of surgical and nonsurgical treatment for hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 2000;32:1224-9.
4. Begg 1994 Begg CB, Mazumar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50(4):1088- 101.
5. Bismuth 2000 Bismuth H, Majno PE. Hepatobiliary surgery. Journal of Hepatology 2000;32:208-24.
6. Bosch 2004 Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:S5-S16.
7. Bruix 2001 Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al.Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. Journal of Hepatology 2001;35:421-30.
8. Calle 2003 Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality of cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine 2003;348:1625-38.
9. Coleman 2003 Coleman MP, Gatta G, Verdeccia A, Esteve J, Sant M, Storm H, et al.EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Annals of Oncology 2003;14(Suppl 5):V128-V149.
10. Egger 1997 Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analyses detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-34.
11. El Serag 1999 El Serag HB, Mason AC. Rising incide of hepatocellular carcinoma in the United States. New England Journal of Medicine 1999;340:745-50.
12. El Serag 2004 El-Serag H. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004;127:S27-S34.
13. El Serag 2004a El Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-8.
14. Galandi 2004 Galandi D, Antes G. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003046. DOI: 10.1002/14651858. CD003046.pub2.
15. Gluud 2007 Gluud C, Nikolova D, Klingenberg SL, Als-Nielsen B, D'Amico G, Davidson B, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2007, Issue 2. Art. No.: LIVER.
16. Heffernan 2002 Heffernan N, Webster K, Odom L, Martone M, Passik S, Bookbinder M, et al.Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy - hepatobiliary questionnaire. Journal of Clinical Oncology 2002;20(9):2229-39.
17. Higgins 2002 Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
18. Higgins 2006 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & sons, Ltd.
19. Hollis 1999 Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised trials. BMJ (Clinical Research Ed.) 1999;319(7211):670-4.
20. ICH-GCP 1997 International Conference on Harmonisation of Technical Requiements for Registration of Pharmaceuticals for Human Use. Code of Federal Regulation & ICH Guidelines. Media: Parexel Barnett, 1997.
21. Lencioni 1997 Lencioni R, Pinto F, Bassi AM, Moretti M, Di Giulio M, Marchi S, et al.Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: an European experience. European Radiology 1997;7:514-9.
22. Lencioni 2003 Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al.Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228(1):235-40.
23. Livraghi 1995 Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolodi L, et al.Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197(1):101-8.
24. Llovet 2000 Llovet JM, Sala M, Castells L, Suarez Y, Vilana R, Bianchi L, et al.Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology 2000;31:54-8.
25. Lopez 2006 Lopez PM, Villanueva A, Llovet JM. Systematic review: evidence-based management of hepatocellular carcinoma - un updated analysis of randomized controlled trials. Alimentary Pharmacology & Therapeutics 2006;23:1535-47.
26. Macaskill 2001 Mackaskill P, Walter SD, Irwing L. A comparison of methods to detect publication bias in meta-analysis. Statistics in Medicine 2001;20:641-54.
27. Machin 1997 Machin D, Stenning SP, Parmar MK, Fayers PM, Girling DJ, Stephens RJ, et al.Thirty years of Medical Research Council randomized trials in solid tumours. Clinical Oncology 1997;9:100-14.
28. Mazzaferro 1996 Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New England Journal of Medicine 1996;334:693-9.
29. Miller 1981 Miller AB, Hogstraeten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
30. Ohnishi 1996 Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. Hepatology 1996;24:1379-85.
31. Ohnishi 1998 Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998;27:67-72.
32. Parkin 2001 Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the World Cancer Burden: GLOBOCAN 2000. International Journal of Cancer 2001;94:153-6.
33. Parmar 1998 Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival end-points. Statistics in Medicine 1998;17:2815-34.
34. RevMan 2003 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
35. Ries 2007 Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al.SEER cancer statistics. http://seer.cancer.gov/csr/1975_2001/ accessed 14 May 2007.
36. Royle 2003 Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603.
37. Schulz 1994 Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in Obstetrics and Gynecology Journals. JAMA 1994;272(2):125-8.
38. Sørensen 2003 Sørensen HT, Mellemkjær L, Jepsen P, Thulstrup AM, Baron J, Olsen JH, et al.Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study. Journal of Clinical Gastroeterology 2003;36:356-9.
39. Takamori 2000 Takamori R, Wong LL, Dang C, Wong L. Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always neccessary?. Liver Transplantation 2000;6:67-72.
40. Therasse 2000 Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al.New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Institute 2000;92(3):205-16.